A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
Public ClinicalTrials.gov record NCT02694328. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate weight gain of ALKS 3831 compared to olanzapine in adult subjects with schizophrenia.
Study identification
- NCT ID
- NCT02694328
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 561 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2, 2016 (Actual)
- Primary completion
- Nov 7, 2018 (Actual)
- Completion
- Nov 7, 2018 (Actual)
- Last update posted
- Feb 10, 2020
2016 – 2018
United States locations
- U.S. sites
- 52
- U.S. states
- 16
- U.S. cities
- 49
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alkermes Investigational Site | Little Rock | Arkansas | 72211 | — |
| Alkermes Investigational Site | Springdale | Arkansas | 72764 | — |
| Alkermes Investigational Site | Anaheim | California | 92805 | — |
| Alkermes Investigational Site | Cerritos | California | 90703 | — |
| Alkermes Investigational Site | Culver City | California | 90230 | — |
| Alkermes Investigational Site | Garden Grove | California | 92845 | — |
| Alkermes Investigational Site | Glendale | California | 91206 | — |
| Alkermes Investigational Site | Long Beach | California | 90822 | — |
| Alkermes Investigational Site | National City | California | 91950 | — |
| Alkermes Investigational Site | Oakland | California | 94612 | — |
| Alkermes Investigational Site | Oceanside | California | 92056 | — |
| Alkermes Investigational Site | Orange | California | 92868 | — |
| Alkermes Investigational Site | Pico Rivera | California | 90660 | — |
| Alkermes Investigational Site | Redlands | California | 92374 | — |
| Alkermes Investigational Site | San Diego | California | 92103 | — |
| Alkermes Investigational Site | San Diego | California | 92123 | — |
| Alkermes Investigational Site | Temecula | California | 92591 | — |
| Alkermes Investigational Site | Torrance | California | 90502 | — |
| Alkermes Investigational Site | Washington D.C. | District of Columbia | 20016 | — |
| Alkermes Investigational Site | Lauderhill | Florida | 33319 | — |
| Alkermes Investigational Site | Miami | Florida | 33136 | — |
| Alkermes Investigational Site | North Miami | Florida | 33161 | — |
| Alkermes Investigational Site | Oakland Park | Florida | 33334 | — |
| Alkermes Investigational Site | Tampa | Florida | 33609 | — |
| Alkermes Investigational Site | Atlanta | Georgia | 30329 | — |
| Alkermes Investigational Site | Augusta | Georgia | 30912 | — |
| Alkermes Investigational Site | Decatur | Georgia | 30030 | — |
| Alkermes Investigational Site | Chicago | Illinois | 60640 | — |
| Alkermes Investigational Site | Grand Rapids | Michigan | 49503 | — |
| Alkermes Investigational Site | Flowood | Mississippi | 39232 | — |
| Alkermes Investigational Site | Creve Coeur | Missouri | 63141 | — |
| Alkermes Investigational Site | O'Fallon | Missouri | 63368 | — |
| Alkermes Investigational Site | St Louis | Missouri | 63128 | — |
| Alkermes Investigational Site | Las Vegas | Nevada | 89102 | — |
| Alkermes Investigational Site | Berlin | New Jersey | 08009 | — |
| Alkermes Investigational Site | Marlton | New Jersey | 08053 | — |
| Alkermes Investigational Site | Brooklyn | New York | 11235 | — |
| Alkermes Investigational Site | Jamaica | New York | 11432 | — |
| Alkermes Investigational Site | New York | New York | 10032 | — |
| Alkermes Investigational Site | New York | New York | 10035 | — |
| Alkermes Investigational Site | Rochester | New York | 14615 | — |
| Alkermes Investigational Site | Wards Island | New York | 10035 | — |
| Alkermes Investigational Site | Canton | Ohio | 44718 | — |
| Alkermes Investigational Site | Dayton | Ohio | 45417 | — |
| Alkermes Investigational Site | Middleburg Heights | Ohio | 44130 | — |
| Alkermes Investigational Site | Allentown | Pennsylvania | 18104 | — |
| Alkermes Investigational Site | Austin | Texas | 78754 | — |
| Alkermes Investigational Site | Austin | Texas | 78759 | — |
| Alkermes Investigational Site | Dallas | Texas | 75243 | — |
| Alkermes Investigational Site | DeSoto | Texas | 75115 | — |
| Alkermes Investigational Site | Houston | Texas | 77030 | — |
| Alkermes Investigational Site | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02694328, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 10, 2020 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02694328 live on ClinicalTrials.gov.